MD · XBRL financial data

Pediatrix Medical Group financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MD's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
General and administrative	249	263	231	228	238	241
Total operating expenses	1,636	1,708	1,799	1,987	2,082	1,705
Operating income (loss)	98	203	173	7	(69)	209
Interest expense	110	69	40	42	41	36
Income tax expense (benefit)	17	27	19	12	(2)	51
Net income (loss)	(796)	131	66	(60)	(99)	165
Earnings per share, basic USD per share	(9.55)	1.54	0.79	0.73	(1.19)	1.97
Earnings per share, diluted USD per share	(9.55)	1.53	0.79	0.73	(1.19)	1.94
Weighted average shares, basic millions of shares	83	85	83	82	83	84
Weighted average shares, diluted millions of shares	83	86	84	82	83	85

Fiscal years (MD's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,124	387	10	73	230	375
Marketable securities	105	100	93	104	119	124
Accounts receivable	242	302	297	272	260	230
Total current assets	1,549	841	428	483	640	764
Property and equipment, net	76	70	73	76	39	39
Right-of-use asset	45	51	56	62	34	31
Goodwill	1,478	1,505	1,532	1,384	1,243	1,261
Total assets	3,348	2,723	2,348	2,220	2,153	2,247
Accounts payable	60	37	32	35	46	37
Total current liabilities	444	427	427	389	434	459
Lease liability, non-current	41	41	44	47	32	26
Total liabilities	2,600	1,826	1,456	1,371	1,388	1,381
Retained earnings (accumulated deficit)	(286)	(155)	(89)	149	(249)	(83)
Total stockholders' equity	747	896	892	849	765	866
Total liabilities and equity	3,348	2,723	2,348	2,220	2,153	2,247
Common shares outstanding (cover page) millions of shares	86	86	83	84	86	83

Fiscal years (MD's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(796)	131	66	(60)	(99)	165
Stock-based compensation	39	19	16	12	12	18
Depreciation and amortization	28	32	36	36	32	22
Net cash from operating activities	205	77	167	137	207	271
Net cash from investing activities	816	(53)	(57)	(48)	(35)	(18)
Proceeds from issuing common stock	7	7	5	5	4	3
Share repurchases	8	5	89	1	2	87
Net cash from financing activities	(4)	(760)	(488)	(26)	(14)	(107)
Net change in cash	1,016	(736)	(378)	63	157	145

SIC 8060 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8060 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Pediatrix Medical Group	312	501	117*	78.1M	Q3 FY26 10-QSep 30, 2026
Select Medical Holdings	26	1,421	38	124.0M	Q1 FY26 10-QMar 31, 2026
Community Health Systems	155	2,757	154*	141.0M	Q3 FY26 10-QSep 30, 2026
Ardent Health	724	1,622	197*	141.0M	Q2 FY26 10-QJun 30, 2026
Surgery Partners	217	not reported	59*	130.9M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.